Trials / Unknown
UnknownNCT03112733
Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers
Value of TFF3, SFRP4, Romo1 and NFKB as Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 171 (actual)
- Sponsor
- Ilker Kahramanoglu · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the usefulness of serum levels of trefoil factor 3 (TFF3), secreted frizzled related protein 4 (sFRP-4), reactive oxygen species modulator 1 (Romo1) and nuclear factor (NF)-κB as potential diagnostic and prognostic biomarkers in ovarian carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | TFF3, SFRP4, Romo1, NFKB | Blood samples of all participants will be collected. |
Timeline
- Start date
- 2017-04-04
- Primary completion
- 2018-06-21
- Completion
- 2019-05-30
- First posted
- 2017-04-13
- Last updated
- 2019-02-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03112733. Inclusion in this directory is not an endorsement.